Year: 2021
Type: article
Abstract: mitigated by different dosing strategies, but research in this area is also sparse.Thus, the authors' call for new innovations that address the unique challenges of synthetic opioids is particularly critical, although this must be balanced with the fundamental need to improve all addiction prevention and treatment collectively.As synthetic opioid-related mortality increases in the western United States [9], we can no longer ignore that the fentanyl market is persisting, and need to prioritize research and funding to address this problem.
Source: Addiction
DOI: 10.1111/add.15442
Institutions: RAND Corporation, University of Maryland, College Park
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3130393516